The gold (III) porphyrin complex, gold-2a, suppresses WNT1 expression in breast cancer cells by enhancing the promoter association of YY1.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American journal of translational research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 22046489PMCID PMC3204891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.

  2010cited by this paper
• Yin Yang 1 expression in human tumors

  2010cited by this paper
• A gold(III) porphyrin complex with antitumor properties targets the Wnt/beta-catenin pathway.

  2010influential reference
• A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers

  2010cited by this paper
• Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies

  2010cited by this paper
• The involvement of the transcription factor Yin Yang 1 in cancer development and progression

  2009cited by this paper
• Wnt signaling in mitosis.

  2009cited by this paper
• Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification

  2009cited by this paper
• Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer

  2009cited by this paper
• Metal complexes, their cellular targets and potential for cancer therapy.

  2009cited by this paper
• The role of YY1 in reduced HP1α gene expression in invasive human breast cancer cells

  2009cited by this paper
• Gold(III) porphyrin complex is more potent than cisplatin in inhibiting growth of nasopharyngeal carcinoma in vitro and in vivo

  2009cited by this paper
• New trends for metal complexes with anticancer activity.

  2008cited by this paper
• Anti-cancer potential of gold complexes

  2008cited by this paper
• Gold complexes as prospective metal-based anticancer drugs.

  2008cited by this paper
• Wdr5 Is Essential for Osteoblast Differentiation*

  2008cited by this paper
• Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways.

  2008cited by this paper
• Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.

  2008cited by this paper
• Pax3 regulates Wnt1 expression via a conserved binding site in the 5' proximal promoter.

  2008influential reference
• The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors

  2008cited by this paper
• Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.

  2007cited by this paper
• Chromosomal instability by β-catenin/TCF transcription in APC or β-catenin mutant cells

  2007cited by this paper
• Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1

  2007cited by this paper
• The role of the APC tumor suppressor in chromosomal instability.

  2006cited by this paper
• Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer.

  2006cited by this paper
• CIN by WNT: Growth Pathways, Mitotic Control and Chromosomal Instability in Cancer

  2006cited by this paper
• Transcription factor YY1: structure, function, and therapeutic implications in cancer biology

  2006cited by this paper
• Polycomb recruitment to DNA in vivo by the YY1 REPO domain

  2006cited by this paper
• Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma

  2006cited by this paper
• Suz12 binds to silenced regions of the genome in a cell-type-specific manner.

  2006influential reference
• Essential Dosage-Dependent Functions of the Transcription Factor Yin Yang 1 in Late Embryonic Development and Cell Cycle Progression

  2006cited by this paper
• Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.

  2006cited by this paper
• GoldIII porphyrin 1a induced apoptosis by mitochondrial death pathways related to reactive oxygen species.

  2005cited by this paper
• Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species

  2005cited by this paper
• MatInspector and beyond: promoter analysis based on transcription factor binding sites

  2005cited by this paper
• Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis

  2005cited by this paper
• Mechanisms of cytotoxicity of selected organogold(III) compounds.

  2005cited by this paper
• Applied bioinformatics for the identification of regulatory elements

  2004cited by this paper
• Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

  2004cited by this paper
• Six3 repression of Wnt signaling in the anterior neuroectoderm is essential for vertebrate forebrain development.

  2003cited by this paper
• New metal complexes as potential therapeutics.

  2003cited by this paper
• The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase

  2003cited by this paper
• Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells.

  2003cited by this paper
• Regulation of Transcription Factor YY1 by Acetylation and Deacetylation

  2001cited by this paper
• Gold-based therapeutic agents.

  1999cited by this paper
• Gold-Based Therapeutic Agents

  1999cited by this paper
• Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL

  1998cited by this paper
• Identification of an evolutionarily conserved 110 base-pair cis-acting regulatory sequence that governs Wnt-1 expression in the murine neural plate.

  1998cited by this paper
• A 5.5-kb enhancer is both necessary and sufficient for regulation of Wnt-1 transcription in vivo.

  1997cited by this paper
• Databases on transcriptional regulation : TRANSFAC , TRRD and COMPEL

  1997cited by this paper
• Cis-acting regulatory sequences governing Wnt-1 expression in the developing mouse CNS.

  1994cited by this paper
• Wnt-1-inducing factor-1: a novel G/C box-binding transcription factor regulating the expression of Wnt-1 during neuroectodermal differentiation

  1993cited by this paper
• The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus

  1990cited by this paper
• Transient expression of the proto-oncogene int-1 during differentiation of P19 embryonal carcinoma cells

  1989cited by this paper
• Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

  1982cited by this paper

• Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation

  2025cites this paper
• Multifunctional Microparticles Incorporating Gold Compound Inhibit Human Lung Cancer Xenograft

  2020cites this paper
• Biological Activity of Au(III) Complexes

  2019cites this paper
• BIOLOGICAL ACTIVITY OF AU(III) COMPLEXES BIOLOŠKA AKTIVNOST ZLATO(III)-KOMPLEKSA

  2019cites this paper